Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance

BACKGROUND: Drug resistance continues to be a major limiting factor across diverse anti-cancer therapies. Contributing to the complexity of this challenge is cancer plasticity, in which one cancer subtype switches to another in response to treatment, for example, triple-negative breast cancer (TNBC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhatib, Heba, Rubinstein, Ariel M., Vasudevan, Swetha, Flashner-Abramson, Efrat, Stefansky, Shira, Chowdhury, Sangita Roy, Oguche, Solomon, Peretz-Yablonsky, Tamar, Granit, Avital, Granot, Zvi, Ben-Porath, Ittai, Sheva, Kim, Feldman, Jon, Cohen, Noa E., Meirovitz, Amichay, Kravchenko-Balasha, Nataly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583500/
https://www.ncbi.nlm.nih.gov/pubmed/36266692
http://dx.doi.org/10.1186/s13073-022-01121-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583500/
https://www.ncbi.nlm.nih.gov/pubmed/36266692
http://dx.doi.org/10.1186/s13073-022-01121-y

Ejemplares similares